Generic placeholder image

Current Pharmacogenomics and Personalized Medicine

Editor-in-Chief

ISSN (Print): 1875-6921
ISSN (Online): 1875-6913

Commentary

Sex and Gender Differences in Medical Education: The Impact on Scientific Reports

Author(s): Anna Vittoria Mattioli*, Francesca Coppi, Valentina Bucciarelli, Milena Nasi, Marcello Pinti, Carla Palumbo and Sabina Gallina

Volume 20, Issue 2, 2023

Published on: 07 September, 2023

Page: [128 - 133] Pages: 6

DOI: 10.2174/1875692120666230811092856

Price: $65

Abstract

This commentary explores the reasons why sex and gender differences must be included in medical education and the impact on healthcare outcomes for patients. Understanding sex and gender differences could be useful in making more accurate diagnoses and to develop more effective treatment plans. Sex and gender medicine take into consideration both the genetic basis and the effects of exposure to environmental and socio-economic factors.

Graphical Abstract

[1]
Göttgens I, Oertelt-Prigione S. Moving beyond gender identity: The need for contextualization in gender-sensitive medical research. Lancet Reg Health Eur 2023; 24: 100548.
[http://dx.doi.org/10.1016/j.lanepe.2022.100548] [PMID: 36643661]
[2]
Mattioli AV, Nasi M, Pinti M, Palumbo C. Teaching gender differences at medical school could improve the safety and efficacy of personalized physical activity prescription. Front Cardiovasc Med 2022; 9: 919257.
[http://dx.doi.org/10.3389/fcvm.2022.919257] [PMID: 35811713]
[3]
Franconi F, Campesi I, Colombo D, Antonini P. Sex-gender variable: Methodological recommendations for increasing scientific value of clinical studies. Cells 2019; 8(5): 476.
[http://dx.doi.org/10.3390/cells8050476] [PMID: 31109006]
[4]
Regensteiner JG, Reusch JEB. Sex differences in cardiovascular consequences of hypertension, obesity, and diabetes. J Am Coll Cardiol 2022; 79(15): 1492-505.
[http://dx.doi.org/10.1016/j.jacc.2022.02.010] [PMID: 35422246]
[5]
Gentilin A, Moghetti P, Cevese A, Mattioli AV, Schena F, Tarperi C. Circadian and sex differences in carotid-femoral pulse wave velocity in young individuals and elderly with and without type 2 diabetes. Front Cardiovasc Med 2022; 9: 952621.
[http://dx.doi.org/10.3389/fcvm.2022.952621] [PMID: 36158808]
[6]
Woodward M. Cardiovascular disease and the female disadvantage. Int J Environ Res Public Health 2019; 16(7): 1165.
[http://dx.doi.org/10.3390/ijerph16071165] [PMID: 30939754]
[7]
Gogovor A, Zomahoun HTV, Ekanmian G, et al. Sex and gender considerations in reporting guidelines for health research: A systematic review. Biol Sex Differ 2021; 12(1): 62.
[http://dx.doi.org/10.1186/s13293-021-00404-0] [PMID: 34801060]
[8]
Lunova T, Komorovsky R, Klishch I. Gender differences in treatment delays, management and mortality among patients with acute coronary syndrome: A systematic review and meta-analysis. Curr Cardiol Rev 2023; 19(1): e300622206530.
[http://dx.doi.org/10.2174/1573403X18666220630120259] [PMID: 35786190]
[9]
Kusnoor AV, Ferguson AD, Falik R. Ischemic heart disease in women: A review for primary care physicians. South Med J 2011; 104(3): 200-4.
[http://dx.doi.org/10.1097/SMJ.0b013e31820bffd3] [PMID: 21297529]
[10]
Mattioli AV, Moscucci F, Sciomer S, et al. Cardiovascular prevention in women: An update by the Italian Society of Cardiology working group on ‘Prevention, hypertension and peripheral disease’. J Cardiovasc Med 2023; 24 (Suppl. 2): e147-55.
[http://dx.doi.org/10.2459/JCM.0000000000001423] [PMID: 37186565]
[11]
Deraz O, Caceres B, Streed CG Jr, et al. Sexual minority status disparities in life’s essential 8 and life’s simple 7 cardiovascular health scores: A french nationwide population-based study. J Am Heart Assoc 2023; 12(11): e028429.
[http://dx.doi.org/10.1161/JAHA.122.028429] [PMID: 37195318]
[12]
Santos JD, Oliveira-Neto JT, Tostes RC. The cardiovascular subtleties of testosterone on gender-affirming hormone therapy. Am J Physiol Heart Circ Physiol 2023; 325(1): H30-53.
[http://dx.doi.org/10.1152/ajpheart.00015.2023] [PMID: 37145958]
[13]
Rebić N, Law MR, Cragg J, et al. What's sex and gender got to do with it?" A scoping review of sex and genderbased analysis in pharmacoepidemiologic studies of medication adherence. Value Health 2023; S1098-3015(23): 02559-7.
[http://dx.doi.org/10.1016/j.jval.2023.04.002]
[14]
Masumori N, Nakatsuka M. Cardiovascular risk in transgender people with gender-affirming hormone treatment. Circ Rep 2023; 5(4): 105-13.
[http://dx.doi.org/10.1253/circrep.CR-23-0021] [PMID: 37025940]
[15]
Sabin J, Guenther G, Ornelas IJ, et al. Brief online implicit bias education increases bias awareness among clinical teaching faculty. Med Educ Online 2022; 27(1): 2025307.
[http://dx.doi.org/10.1080/10872981.2021.2025307] [PMID: 35037585]
[16]
Cocchi C, Coppi F, Farinetti A, Mattioli AV. Cardiovascular disease prevention and therapy in women with Type 2 diabetes. Future Cardiol 2021; 17(3): 487-96.
[http://dx.doi.org/10.2217/fca-2021-0011] [PMID: 33739145]
[17]
Hui K, Sukhera J, Vigod S, Taylor VH, Zaheer J. Recognizing and addressing implicit gender bias in medicine. CMAJ 2020; 192(42): E1269-70.
[http://dx.doi.org/10.1503/cmaj.200286] [PMID: 33077523]
[18]
Harper LJ, Kidambi P, Kirincich JM, Thornton JD, Khatri S, Culver DA. Health disparities: Interventions for pulmonary disease : A narrative review. Chest 2023; S0012-3692(23): 00302-1.
[http://dx.doi.org/10.1016/j.chest.2023.02.033]
[19]
Humphries KH, Izadnegahdar M, Sedlak T, et al. Sex differences in cardiovascular disease - Impact on care and outcomes. Front Neuroendocrinol 2017; 46: 46-70.
[http://dx.doi.org/10.1016/j.yfrne.2017.04.001] [PMID: 28428055]
[20]
Ruder K. Large study finds women are (Still) much more likely to die or have complications after coronary artery bypass graft surgery than men. JAMA 2023; 329(11): 872-3.
[http://dx.doi.org/10.1001/jama.2023.1806] [PMID: 36857088]
[21]
Gender Studies in Product Development. Historical Overview:. 2018. Available from: https://www.fda.gov/science-research/womens-health-research/gender-studies-product-development-historical-overview
[22]
Bierer BE, Meloney LG, Ahmed HR, White SA. Advancing the inclusion of underrepresented women in clinical research. Cell Rep Med 2022; 3(4): 100553.
[http://dx.doi.org/10.1016/j.xcrm.2022.100553] [PMID: 35492242]
[23]
Bierer BE, Meloney LG. Strategies to optimize inclusion of women in multi-national clinical trials. Contemp Clin Trials 2022; 117: 106770.
[http://dx.doi.org/10.1016/j.cct.2022.106770] [PMID: 35500726]
[24]
Mattioli AV, Selleri V, Zanini G, et al. Physical activity and diet in older women: A narrative review. J Clin Med 2022; 12(1): 81.
[http://dx.doi.org/10.3390/jcm12010081] [PMID: 36614882]
[25]
Franconi F, Brunelleschi S, Steardo L, Cuomo V. Gender differences in drug responses. Pharmacol Res 2007; 55(2): 81-95.
[http://dx.doi.org/10.1016/j.phrs.2006.11.001] [PMID: 17129734]
[26]
Tran C, Knowles SR, Liu BA, Shear NH. Gender differences in adverse drug reactions. J Clin Pharmacol 1998; 38(11): 1003-9.
[http://dx.doi.org/10.1177/009127009803801103] [PMID: 9824780]
[27]
Paolisso P, Bergamaschi L, Saturi G, D’Angelo EC, Magnani I. Seconary prevention medical therapy and outcomes in patients with myocardial infarction with non-obstructive coronary artery disdease. Front Pharmacol 2020; 10: 1606.
[http://dx.doi.org/10.3389/fphar.2019.01606] [PMID: 32082147]
[28]
Montemitro C, Cavallotto C, Giovannetti G, et al. Analysis of female enrollment in clinical trials for alcohol and substance use disorders: Is it time for sex-informed pharmacotherapy? Contemp Clin Trials 2022; 118: 106784.
[http://dx.doi.org/10.1016/j.cct.2022.106784] [PMID: 35618230]
[29]
Olubodun JO, Ochs HR, Von Moltke LL, et al. Pharmacokinetic properties of zolpidem in elderly and young adults: Possible modulation by testosterone in men. Br J Clin Pharmacol 2003; 56(3): 297-304.
[http://dx.doi.org/10.1046/j.0306-5251.2003.01852.x] [PMID: 12919178]
[30]
Os I, Bratland B, Dahlöf B, Gisholt K, Syvertsen JO, Tretli S. Female preponderance for lisinopril-induced cough in hypertension. Am J Hypertens 1994; 7(11): 1012-5.
[http://dx.doi.org/10.1093/ajh/7.11.1012] [PMID: 7848615]
[31]
Shan Y, Cheung L, Zhou Y, Huang Y, Huang RS. A systematic review on sex differences in adverse drug reactions related to psychotropic, cardiovascular, and analgesic medications. Front Pharmacol 2023; 14: 1096366.
[http://dx.doi.org/10.3389/fphar.2023.1096366] [PMID: 37201021]
[32]
Essebag V, Reynolds MR, Hadjis T, et al. Sex differences in the relationship between amiodarone use and the need for permanent pacing in patients with atrial fibrillation. Arch Intern Med 2007; 167(15): 1648-53.
[http://dx.doi.org/10.1001/archinte.167.15.1648] [PMID: 17698688]
[33]
Roten L, Rimoldi SF, Schwick N, Sakata T, Heimgartner C, Fuhrer J, et al. Gender differences in patients referred for atrial fibrillation management to a tertiary center. Pacing Clin Electrophysiol 2009; 32(5): 622.
[http://dx.doi.org/10.1111/j.1540-8159.2009.02335.x]
[34]
van Erven L, Schalij MJ. Amiodarone: An effective antiarrhythmic drug with unusual side effects. Heart 2010; 96(19): 1593-600.
[http://dx.doi.org/10.1136/hrt.2008.152652] [PMID: 20837671]
[35]
D’Ascenzi F, Sciaccaluga C, Cameli M, et al. When should cardiovascular prevention begin? The importance of antenatal, perinatal and primordial prevention. Eur J Prev Cardiol 2019; 28(4): 361-9.
[http://dx.doi.org/10.1177/2047487319893832] [PMID: 33611390]
[36]
Khan SS, Brewer LC, Canobbio MM, et al. Optimizing prepregnancy cardiovascular health to improve outcomes in pregnant and postpartum individuals and offspring: A scientific statement from the American Heart Association. Circulation 2023; 147(7): e76-91.
[http://dx.doi.org/10.1161/CIR.0000000000001124] [PMID: 36780391]
[37]
Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: The American Heart Association’s strategic Impact Goal through 2020 and beyond. Circulation 2010; 121(4): 586-613.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.109.192703] [PMID: 20089546]
[38]
Vogel B, Acevedo M, Appelman Y, et al. The Lancet women and cardiovascular disease Commission: Reducing the global burden by 2030. Lancet 2021; 397(10292): 2385-438.
[http://dx.doi.org/10.1016/S0140-6736(21)00684-X] [PMID: 34010613]
[39]
Johnathan T, Adrianne M, Katherine A, et al. Mietlicki-Baase, Macronutrient intake: Hormonal controls, pathological states, and methodological considerations. Appetite 2023; 180: 106365.
[40]
Vlassoff C. Gender differences in determinants and consequences of health and illness. J Health Popul Nutr 2007; 25(1): 47-61.
[PMID: 17615903]
[41]
Coppi F, Nasi M, Farinetti A, Manenti A, Gallina S, Mattioli AV. Physical Activity, Sedentary Behaviour, and Diet in Menopausal Women: Comparison Between COVID19 “first wave” and “second wave” of Pandemic in Italy. Prog Nutr 2021; 23: e2021194.
[42]
McKenzie BL, Santos JA, Geldsetzer P, et al. Evaluation of sex differences in dietary behaviours and their relationship with cardiovascular risk factors: A cross-sectional study of nationally representative surveys in seven low- and middle-income countries. Nutr J 2020; 19(1): 3.
[http://dx.doi.org/10.1186/s12937-019-0517-4] [PMID: 31928531]
[43]
Kittithaworn A, Toro-Tobon D, Sfeir JG. Cardiovascular benefits and risks associated with calcium, vitamin D, and antiresorptive therapy in the management of skeletal fragility. Womens Health 2023; 19: 17455057231170059.
[http://dx.doi.org/10.1177/17455057231170059] [PMID: 37129172]
[44]
Sandberg AS, Scheers N. Phytic acid: Properties, uses, and determination. In: Benjamin C, Paul MF, Fidel T, Eds. Encyclopedia of Food and Health. Academic Press 2016; pp. 365-8.
[http://dx.doi.org/10.1016/B978-0-12-384947-2.00544-4]
[45]
Di Natale C, Lucidi L, Montemitro C, et al. Gender differences in the psychopathology of obesity: How relevant is the role of binge eating behaviors? Brain Sci 2022; 12(7): 955.
[http://dx.doi.org/10.3390/brainsci12070955] [PMID: 35884761]
[46]
Rocha-Rodrigues S, Sousa M, Lourenço Reis P, et al. Bidirectional interactions between the menstrual cycle, exercise training, and macronutrient intake in women: A review. Nutrients 2021; 13(2): 438.
[http://dx.doi.org/10.3390/nu13020438] [PMID: 33572821]
[47]
Bardhan P, Yang T. Sexual dimorphic interplays between gut microbiota and antihypertensive drugs. Curr Hypertens Rep 2023; 25(8): 163-72.
[http://dx.doi.org/10.1007/s11906-023-01244-6] [PMID: 37199902]
[48]
Valeri F, Endres K. How biological sex of the host shapes its gut microbiota. Front Neuroendocrinol 2021; 61: 100912.
[http://dx.doi.org/10.1016/j.yfrne.2021.100912] [PMID: 33713673]
[49]
Miller V, Yusuf S, Chow CK, et al. Availability, affordability, and consumption of fruits and vegetables in 18 countries across income levels: Findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet Glob Health 2016; 4(10): e695-703.
[http://dx.doi.org/10.1016/S2214-109X(16)30186-3] [PMID: 27567348]
[50]
Mattioli AV, Francesca C, Mario M, Alberto F. Fruit and vegetables in hypertensive women with asymptomatic peripheral arterial disease. Clin Nutr ESPEN 2018; 27: 110-2.
[http://dx.doi.org/10.1016/j.clnesp.2018.05.010] [PMID: 30144882]
[51]
Bucciarelli V, Nasi M, Bianco F, et al. Depression pandemic and cardiovascular risk in the COVID-19 era and long COVID syndrome: Gender makes a difference. Trends Cardiovasc Med 2022; 32(1): 12-7.
[http://dx.doi.org/10.1016/j.tcm.2021.09.009] [PMID: 34619336]
[52]
The Lancet Public Health. Time to tackle the physical activity gender gap. Lancet Public Health 2019; 4(8): e360.
[http://dx.doi.org/10.1016/S2468-2667(19)30135-5] [PMID: 31345750]
[53]
Ricci F, Izzicupo P, Moscucci F, et al. Recommendations for physical inactivity and sedentary behavior during COVID-19. Front Public Health 2020; 8: 199.
[http://dx.doi.org/10.3389/fpubh.2020.00199] [PMID: 32574294]
[54]
Klein R, Julian KA, Snyder ED, et al. Gender bias in resident assessment in graduate medical education: Review of the literature. J Gen Intern Med 2019; 34(5): 712-9.
[http://dx.doi.org/10.1007/s11606-019-04884-0] [PMID: 30993611]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy